Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study
Ingrid Hokstad, Gia Deyab, Morten Wang Fagerland, et al.
PLoS ONE (2019) Vol. 14, Iss. 7, pp. e0220079-e0220079
Open Access | Times Cited: 21

Showing 21 citing articles:

Soluble Membrane Attack Complex: Biochemistry and Immunobiology
Scott R. Barnum, Doryen Bubeck, Theresa N. Schein
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 49
Overview on the Link Between the Complement System and Auto-Immune Articular and Pulmonary Disease
Paola Triggianese, Paola Conigliaro, Erica De Martino, et al.
Open Access Rheumatology Research and Reviews (2023) Vol. Volume 15, pp. 65-79
Open Access | Times Cited: 10
Effects of Therapies on Cardiovascular Events in Ankylosing Spondylitis: A Systematic Review and Meta-Analysis
Paras Karmacharya, Ravi Shahukhal, Cynthia S. Crowson, et al.
Rheumatology and Therapy (2020) Vol. 7, Iss. 4, pp. 993-1009
Open Access | Times Cited: 18
Ankylosing Spondylitis Pathogenesis and Pathophysiology
Malini Alexander
IntechOpen eBooks (2023)
Open Access | Times Cited: 4
Exploring complement biomarkers in suspected axial spondyloarthritis
Clara Mistegård Jørgensen, Anne Troldborg, Anne Gitte Loft, et al.
RMD Open (2024) Vol. 10, Iss. 2, pp. e004127-e004127
Open Access | Times Cited: 1
Complete Description of the Three Pathways of the Complement System in a Series of 430 Patients with Rheumatoid Arthritis
Dara Rodríguez-González, María García-González, Fuensanta Gómez-Bernal, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8360-8360
Open Access | Times Cited: 1
Ezetimibe ameliorates clinical symptoms in a mouse model of ankylosing spondylitis associated with suppression of Th17 differentiation
Jeonghyeon Moon, Seon-Yeong Lee, Hyun Sik Na, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis
Thao H. Nguyen, Ingrid Hokstad, Morten Wang Fagerland, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0264628-e0264628
Open Access | Times Cited: 6
Hypoxia-associated genes predicting future risk of myocardial infarction: a GEO database-based study
Shaohua Li, Junwen Zhang, Jingwei Ni, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Factors Associated with the Risk of Major Adverse Cardiovascular Events in Patients with Ankylosing Spondylitis: A Nationwide, Population-Based Case—Control Study
Chung-Mao Kao, Jun‐Sing Wang, Wei-Li Ho, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 7, pp. 4098-4098
Open Access | Times Cited: 5
Benefits of tumor necrosis factor inhibitors for cardiovascular disease in ankylosing spondylitis
Jinxian Huang, Yung‐Heng Lee, James Cheng‐Chung Wei
International Immunopharmacology (2022) Vol. 112, pp. 109207-109207
Closed Access | Times Cited: 5
Complement Proteins L-Ficolin and M-Ficolin Are Increased in Patients With Axial Spondyloarthritis and Decrease After Tumor Necrosis Factor Inhibitor Treatment
Clara Elbæk Mistegaard, Anne Troldborg, Annette G. Hansen, et al.
The Journal of Rheumatology (2023) Vol. 51, Iss. 1, pp. 31-38
Closed Access | Times Cited: 2
Related Risk Factors and Treatment Management of Psoriatic Arthritis Complicated With Cardiovascular Disease
Zhoulan Zheng, Qianyu Guo, Dan Ma, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 4
Synovial Complement Factors in Patients with Periprosthetic Joint Infection after Undergoing Revision Arthroplasty of the Hip or Knee Joint
Frank Sebastian Fröschen, Sophia Schell, Matthias Wimmer, et al.
Diagnostics (2021) Vol. 11, Iss. 3, pp. 434-434
Open Access | Times Cited: 5
The Complement System in Spondyloarthritis: What Do We Know?
Clara Elbæk Mistegaard, Fabian Proft
touchREVIEWS in RMD (2022) Vol. 1, Iss. 2, pp. 50-50
Open Access | Times Cited: 3
Complement proteins in axial spondyloarthritis: associations with disease activity and TNFi treatment response in a multicenter randomised controlled trial
Clara Mistegård Jørgensen, Anne Troldborg, Murat Torğutalp, et al.
Rheumatology Advances in Practice (2024) Vol. 9, Iss. 1
Open Access
Subclinical atherosclerosis: A hidden threat for patients with ankylosing spondylitis
Wafa Hamdi, Kaouther Maatallah
The Anatolian Journal of Cardiology (2019)
Open Access | Times Cited: 1
Novel approaches to develop biomarkers predicting treatment responses to TNF-blockers
Ikram Mezghiche, Hanane Yahia‐Cherbal, Lars Rogge, et al.
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 4, pp. 331-354
Open Access | Times Cited: 1
Complement C3d is not associated with axial spondyloarthritis and magnetic resonance imaging changes at the sacroiliac joint
A. Nygaard, Oliver Hendricks, Anne Gitte Loft, et al.
Scandinavian Journal of Rheumatology (2021) Vol. 51, Iss. 5, pp. 382-389
Open Access | Times Cited: 1
Radiographic structural damage predicted increased epicardial adipose tissue thickness in Spondyloarthritis
A. Ben Tekaya, T. Mehmli, O. Saidane, et al.
Research Square (Research Square) (2022)
Open Access
Ankylosing Spondylitis - Recent Concepts
Jácome Bruges‐Armas, R. Ionescu, Horațiu Popoviciu, et al.
IntechOpen eBooks (2022)
Open Access
Page 1

Scroll to top